Evidence map›Paper›PMID 41692746›Full record

ArticleStem cell research & therapy2026

Ningxue Shengban decoction containing serum alleviates immune thrombocytopenia by modulating CD4

Wuxia Yang, Yang Liu, Huiying Kang, Zhen Wang, Yanqi Song, Baoshan Liu, Aidi Wang

Abstract read
In one paragraph

Article in Stem cell research & therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Wuxia YangTianjin Medical University, Tianjin, 300052, People's Republic of China.
Yang LiuTianjin University of Traditional Chinese Medicine, Tianjin, 300052, People's Republic of China.
Huiying KangTianjin University of Traditional Chinese Medicine, Tianjin, 300052, People's Republic of China.
Zhen WangTianjin University of Traditional Chinese Medicine, Tianjin, 300052, People's Republic of China.
Yanqi SongDepartment of Traditional Chinese Medicine, Tianjin Medical University General Hospital, Tianjin, 300052, People's Republic of China.
Baoshan LiuDepartment of Traditional Chinese Medicine, Tianjin Medical University General Hospital, Tianjin, 300052, People's Republic of China. lbs_cd@126.com.
Aidi WangDepartment of Traditional Chinese Medicine, Tianjin Medical University General Hospital, Tianjin, 300052, People's Republic of China. wangaidi@tmu.edu.cn.

Funding

National Natural Science Foundation of China 82374354
6 · The paper itself

Abstract

backgroundThe abnormal immune response mediated by CD4

aimThis study aims to clarify the role of exosomal miR-199a-5p derived from bone marrow mesenchymal stem cells (BMSCs) in immune homeostasis, and to explore the therapeutic effects of exosomes from BMSCs(BMSCs-Exo) pretreated with NXSBD containing serum on ITP.

methodWe co-cultured CD4

resultsOur results indicate that the immunomodulatory effect of BMSCs-Exo on CD4

conclusionIn conclusion, our findings suggest that the therapeutic effect of NXSBD containing serum in ITP mice may be attributed to its upregulation of miR-199a-5p in BMSCs-Exo, which contributes to modulating the immune balance of CD4

Indexed as

CD4-Positive T-LymphocytesDrugs, Chinese HerbalExosomesMesenchymal Stem CellsMicroRNAsPurpura, Thrombocytopenic, IdiopathicAnimalsCell DifferentiationHumansMaleMiceDrugs, Chinese HerbalMicroRNAsMirn199 microRNA, mouseBone marrow mesenchymal stem cellsExosomesImmune thrombocytopeniamiR199a-5pTreg

Identifiers

PMID41692746
PMCPMC13011305

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.